Goldman Sachs raised the firm’s price target on Axis Capital (AXS) to $110 from $103 and keeps a Neutral rating on the shares. In a sector note on Americas Insurance, the firm said it expects “strong and fairly resilient” insurer profitability for the next few years, but added that it believes we are “solidly in the softening phase” of the P&C insurance cycle, which leads to “increased capital supply and competition, which should drive a deceleration in growth/pricing/margins, that we think are broadly underappreciated within Street estimates.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXS:
- Axis Capital price target raised to $130 from $121 at Keefe Bruyette
- Axis Capital: Solid Execution But Emerging Headwinds Limit Upside, Justifying a Neutral (Hold) Stance
- Axis Capital downgraded to Neutral from Buy at BofA
- Axis Capital price target raised to $125 from $113 at BofA
- Axis Capital initiated with an Outperform at Mizuho
